What does Credophar do?
CREDOPHAR specializes in the development and distribution of pharmaceutical products, focusing on high-quality generics. The company is committed to ensuring accessibility and affordability of essential medications for healthcare providers and patients. Through innovation and rigorous quality control, CREDOPHAR aims to meet the evolving needs of the healthcare market.
- Sectors
- Wholesalers
- Signals
-
Poor liquidityPoor liquidity 0.17
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 52KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.93MStrong equity provides a buffer against setbacks.
Positive cashflowPositive cashflow € 32KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 255KPositive EBITDA: operating activities are profitable.
- Shareholders
- Ceres Pharma 100%
- Investments
- Labophar 100%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
258K
|
€
110K
|
€
514K
|
€
1.11M
|
|
|
€
255K
|
€
70K
|
€
507K
|
€
584K
|
|
|
€
52K
|
€
-182K
|
€
201K
|
€
320K
|
|
|
€
1.93M
|
€
1.88M
|
€
2.06M
|
€
1.86M
|
|
|
24.62%
|
24.59%
|
27.00%
|
21.86%
|
|
|
€
5.91M
|
€
5.76M
|
€
5.57M
|
€
6.65M
|
|
|
Cash
|
|
|
|
€
1.09M
|
Publications 13
All publications- Maatschappelijke Zetel - Ontslagen - Benoemingen 16/12/2022
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 08/11/2021
- Ontslagen - Benoemingen - Wijziging Rechtsvorm 17/05/2021
- Kapitaal - Aandelen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 12/05/2021
- Kapitaal - Aandelen - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 23/02/2021
Frequently asked questions
Answers to the most common questions about Credophar, based on official government data and the filed annual accounts.
What is the VAT number of Credophar?
The VAT number of Credophar is BE0849.730.193.
What is the official website of Credophar?
The official website of Credophar is www.credophar.be.
When was Credophar established?
Credophar was founded in 16-10-2012.
What is the official address of Credophar?
The official address of Credophar is Kortrijksesteenweg 1091/B Gent 9051.
What is the legal form of Credophar?
The juridical form of Credophar is Private limited company (BV/SRL).
What is the annual revenue of Credophar?
The 2025 accounts of Credophar do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Credophar do?
CREDOPHAR specializes in the development and distribution of pharmaceutical products, focusing on high-quality generics. The company is committed to ensuring accessibility and affordability of essential medications for healthcare providers and patients. Through innovation and rigorous quality control, CREDOPHAR aims to meet the evolving needs of the healthcare market.
Is Credophar a reliable company?
Credophar is a registered Rechtspersoon with company number 0849.730.193 and can be verified through the official CBE database.
What is the credit limit of Credophar?
The estimated credit limit of Credophar is €247,893.
Is Credophar still active?
Credophar currently has the status "Normal situation" and is active.